190 related articles for article (PubMed ID: 27320601)
1. Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.
Kim BS; Kim JY; Kim EJ; Lee JG; Joo DJ; Huh KH; Kim MS; Kim YS
Transplant Proc; 2016 May; 48(4):1270-4. PubMed ID: 27320601
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.
Kim EJ; Lee JG; Kim JY; Song SH; Joo DJ; Huh KH; Kim MS; Kim BS; Kim YS
Immunology; 2017 Dec; 152(4):628-637. PubMed ID: 28758197
[TBL] [Abstract][Full Text] [Related]
3. Immune modulatory effect of thalidomide on T cells.
Kim BS; Kim JY; Lee JG; Cho Y; Huh KH; Kim MS; Kim YS
Transplant Proc; 2015 Apr; 47(3):787-90. PubMed ID: 25891732
[TBL] [Abstract][Full Text] [Related]
4. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
5. Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.
Voo KS; Bover L; Harline ML; Vien LT; Facchinetti V; Arima K; Kwak LW; Liu YJ
J Immunol; 2013 Oct; 191(7):3641-50. PubMed ID: 24014877
[TBL] [Abstract][Full Text] [Related]
6. GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology.
Lin GH; Snell LM; Wortzman ME; Clouthier DL; Watts TH
J Immunol; 2013 May; 190(9):4627-39. PubMed ID: 23536631
[TBL] [Abstract][Full Text] [Related]
7. TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
Hamano R; Huang J; Yoshimura T; Oppenheim JJ; Chen X
Eur J Immunol; 2011 Jul; 41(7):2010-20. PubMed ID: 21491419
[TBL] [Abstract][Full Text] [Related]
8. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
9. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.
Snell LM; Lin GH; McPherson AJ; Moraes TJ; Watts TH
Immunol Rev; 2011 Nov; 244(1):197-217. PubMed ID: 22017440
[TBL] [Abstract][Full Text] [Related]
10. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.
Valzasina B; Guiducci C; Dislich H; Killeen N; Weinberg AD; Colombo MP
Blood; 2005 Apr; 105(7):2845-51. PubMed ID: 15591118
[TBL] [Abstract][Full Text] [Related]
11. Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells.
Kim EJ; Kim JY; Choi HY; Lee H; Lee J; Kim MS; Kim YS; Huh KH; Kim BS
Yonsei Med J; 2021 Feb; 62(2):137-148. PubMed ID: 33527793
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice.
Liao G; Detre C; Berger SB; Engel P; de Waal Malefyt R; Herzog RW; Bhan AK; Terhorst C
Gastroenterology; 2012 Mar; 142(3):582-591.e8. PubMed ID: 22155173
[TBL] [Abstract][Full Text] [Related]
13. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus].
Alunno A; Nocentini G; Bistoni O; Bianchini R; Bartoloni Bocci E; Riccardi C; Gerli R
Reumatismo; 2010; 62(3):195-201. PubMed ID: 21052566
[TBL] [Abstract][Full Text] [Related]
14. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
[TBL] [Abstract][Full Text] [Related]
15. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in the Gitr locus is regulated by NF-κB and Foxp3 through an enhancer.
Tone Y; Kidani Y; Ogawa C; Yamamoto K; Tsuda M; Peter C; Waldmann H; Tone M
J Immunol; 2014 Apr; 192(8):3915-24. PubMed ID: 24634496
[TBL] [Abstract][Full Text] [Related]
17. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
[TBL] [Abstract][Full Text] [Related]
18. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15.
Snell LM; Lin GH; Watts TH
J Immunol; 2012 Jun; 188(12):5915-23. PubMed ID: 22581858
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.
Ronchetti S; Ricci E; Petrillo MG; Cari L; Migliorati G; Nocentini G; Riccardi C
J Immunol Res; 2015; 2015():171520. PubMed ID: 25961057
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Treg cells/T effector function by GITR signaling is context-dependent.
Ephrem A; Epstein AL; Stephens GL; Thornton AM; Glass D; Shevach EM
Eur J Immunol; 2013 Sep; 43(9):2421-9. PubMed ID: 23722868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
